Business Context and Reporting Period
This Form 8-K is filed by TRxADE HEALTH, INC. (noting a discrepancy with the metadata company name "Scienture Holdings, Inc.") on July 29, 2022. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with continued listing standards on the Nasdaq Capital Market.
Key Financial Metrics
The filing references specific financial data from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022:
- Stockholders' Equity: $1,804,533
- Nasdaq Minimum Requirement: $2,500,000
- Revenue, Profit, Cash Flow, Debt: The filing text does not provide clear values for these metrics.
Material Changes and Non-Compliance
The Company received a notice of noncompliance from Nasdaq because its stockholders' equity of $1,804,533 falls below the required minimum of $2,500,000 under Nasdaq Listing Rule 5550(b)(1). The Company also does not meet alternative continued listing standards. This notice has no immediate impact on the trading of the Company's common stock, which remains listed pending compliance.
Outlook, Risks, and Management Commentary
Compliance Plan and Timeline:
- The Company has until September 12, 2022, to submit a plan to regain compliance.
- If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days to evidence compliance.
- Management is evaluating various courses of action and is confident in regaining compliance, though no assurance is provided.
Risks and Contingencies:
- If the compliance plan is rejected or if the Company fails to regain compliance within the allowed timeframe, Nasdaq could initiate delisting proceedings.
- The Company retains the right to appeal a delisting determination or rejection of a compliance plan to a Nasdaq Hearings Panel.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name ("Scienture Holdings, Inc.") and the registrant name in the filing ("TRxADE HEALTH, INC.").
- Confirm the current stockholders' equity status relative to the $2.5 million Nasdaq threshold.
- Monitor the submission of the compliance plan by the September 12, 2022 deadline.
- Review the Form 10-Q for the quarter ended June 30, 2022, for detailed financial statements not included in this 8-K.